Edgardo Jiménez Fuentes , Oscar Gerardo Arrieta Rodriguez , Ángel Herrera Gómez , Luis Alberto Chinchilla Trigos
{"title":"Metástasis a pulmón: manejo individualizado","authors":"Edgardo Jiménez Fuentes , Oscar Gerardo Arrieta Rodriguez , Ángel Herrera Gómez , Luis Alberto Chinchilla Trigos","doi":"10.1016/j.gamo.2016.09.013","DOIUrl":null,"url":null,"abstract":"<div><p>Lung metastases occur in 20-60% of cases during the natural course of managing cancers. This wide range depends on tumour histology, biological behaviour, clinical stage at diagnosis, type of control of the primary disease, and response to treatment. All this requires the establishment of a thoracic oncology group that is highly familiar with the treatment and behaviour of the primary tumour in order to provide control of secondary lung metastases. There is sufficient evidence to demonstrate that multidisciplinary management of lung metastases is now the best way to improve disease-free survival and increase overall survival with adequate lung function and quality of life.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"15 6","pages":"Pages 350-357"},"PeriodicalIF":0.1000,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2016.09.013","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta Mexicana de Oncologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665920116301134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Lung metastases occur in 20-60% of cases during the natural course of managing cancers. This wide range depends on tumour histology, biological behaviour, clinical stage at diagnosis, type of control of the primary disease, and response to treatment. All this requires the establishment of a thoracic oncology group that is highly familiar with the treatment and behaviour of the primary tumour in order to provide control of secondary lung metastases. There is sufficient evidence to demonstrate that multidisciplinary management of lung metastases is now the best way to improve disease-free survival and increase overall survival with adequate lung function and quality of life.